Foghorn Therapeutics Inc.
USD3.64
+0.01 (+0.28%)
CEO
Adrian H. Gottschalk
IPO Date
2020-10-23
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.62
Prev. Close
$3.63
Day Low
$3.54
Day High
$3.68
52W Low
$3.27
52W High
$6.95
Market Cap
$0.21B
Volume
0.14M
| 47,497 |
| $0.00 |
| 13 Apr 2026 | GOTTSCHALK ADRIAN | director, officer: Chief Executive Officer | G-Gift | Disposed | 59,208 | $0.00 |
| 13 Apr 2026 | GOTTSCHALK ADRIAN | director, officer: Chief Executive Officer | G-Gift | Acquired | 59,208 | $0.00 |
| 24 Feb 2026 | Maynard Ryan D | Chief Financial Officer | A-Award | Acquired | 400,000 | $5.75 |
| 24 Feb 2026 | Maynard Ryan D | — | Disposed | 0 | $0.00 |
| 6 Feb 2026 | GOTTSCHALK ADRIAN | director, officer: Chief Executive Officer | A-Award | Acquired | 1,075,000 | $5.23 |
| 2 Feb 2026 | Costa Carlos | Chief People Officer | A-Award | Acquired | 230,000 | $5.71 |
| 2 Feb 2026 | LaCascia Michael | Chief Legal Officer | A-Award | Acquired | 295,000 | $5.71 |
| 2 Feb 2026 | Cardama Alfonso Quintas | Chief Medical Officer | A-Award | Acquired | 300,000 | $5.71 |